Work

Serum Certolizumab Pegol Levels and Antibodies to Certolizumab Pegol Are Associated With C-Reactive Protein Levels in Patients With Crohn’s Disease

Year: 2014

Type: article

Study design: Observational Study

Source: The American Journal of Gastroenterology

DOI: 10.14309/00000434-201410002-01770

Authors: Andres Yarur, Scott Hauenstein, Frank Czul, Steven Lockton, Maria Quintero, Jamie Barkin, Anjali Jain, Sharat Singh, Maria Abreu

Institutions: University of Miami, Prometheus Biosciences (United States)

Language: English

Topic: Inflammatory Bowel Disease

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2979206298

FWCI:

Cites:

Cited by:

Related to: 10